CAPER: Computerized Assessment of Psychosis Risk
CAPER: Computerized Assessment of Psychosis Risk
批准号:
10569011
负责人:
LAUREN M ELLMAN
金额:
$31.7万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-04-01 至 2025-02-28
关键词:
AddressAmericanAttenuatedAutomobile DrivingBehavioralBiological MarkersClinicalCollaborationsComputing MethodologiesDetectionDeteriorationDiagnosisDimensionsEarly DiagnosisEarly InterventionEarly identificationFoundationsFrequenciesFunctional disorderGenerationsGoalsHuman ResourcesIndividualInternetIntervention TrialInterviewJointsLinkLongitudinal StudiesMachine LearningMeasuresMethodsModelingNeurobiologyOutcomeParticipantPatient Self-ReportPerformancePersonsPopulationPredictive ValuePrimary PreventionPsychopathologyPsychosesPublic HealthPublishingRecording of previous eventsResearchResearch PersonnelRiskRoleSample SizeSecondary PreventionSeveritiesSiteSpecificitySymptomsSystemTechniquesTest ResultTestingTrainingTranslatingUnited StatesWorkYouthclinical high risk for psychosisclinical practicecognitive testingcomputerizeddesignfollow-upfunctional declinefunctional outcomeshelp-seeking behaviorhigh riskhigh risk populationimprovedmachine learning classificationmachine learning methodneuralnew therapeutic targetnext generationonline deliverypreventpreventive interventionpsychosis riskpsychotic symptomsrecruitscreeningsocialtrait
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Research suggests that early identification of individuals at clinical high risk (CHR) for psychosis may be able
to improve illness course. Studies suggest that early identification of CHR using specialized interviews with
help-seeking individuals (with attenuated psychosis symptoms) is a useful approach. This work has two major
limitations: 1) interview methods have limited specificity as only 20% of CHR individuals convert to psychosis,
and 2) the expertise needed to make CHR diagnosis is only accessible in a few academic centers. We propose
to develop a new psychosis symptom domain sensitive (PSDS) battery, prioritizing tasks that show correlations
with the symptoms that define psychosis and are tied to the neurobiological systems and computational
mechanisms implicated in these symptoms. To promote accessibility, we utilize behavioral tasks that could be
administered over the internet; this will set the stage for later research testing widespread screening that would
identify those most in need of in-depth assessment. To reach that goal we first need determine which tasks are
effective for predicting illness course and how this strategy compares to published prediction methods. We
propose to recruit 500 CHR participants, 500 help-seeking individuals, and 500 healthy controls across 5 sites
with the following Aims: Aim 1A) To develop a psychosis risk calculator through the application of machine
learning (ML) methods to the measures from the PSDS battery. In determine an exploratory ML analysis, we will
the added value of combining the PSDS with self-report measures and historical predicators; Aim
1B) We will evaluate group differences on the risk calculator score and hypothesize that the risk calculator
score of the CHR group will differ from help-seeking and healthy controls. We further hypothesize that the risk
calculator score of the CHR converters will differ significantly from groups of CHR nonconverters, help-seeking
and healthy controls. The inclusion of a help-seeking group is critical for translating the risk-calculator into
clinical practice, where the goal is to differentiate those at greatest risk for psychosis from those with other
forms of psychopathology; Aim 1C): Evaluate how baseline PSDS performance relates to symptomatic
outcome 2 years later examining: 1) symptomatic worsening treated as a continuous variable, and 2)
conversion to psychosis. We hypothesize that the PSDS calculator: 1) will predict symptom course and, 2)
that the differences observed between converters and nonconverters will be larger on the PSDS calculator
than on the NAPLS calculator. Aim 2) Use ML methods, as above, to develop calculators that predict: 2A)
social, and, 2B) role function deterioration, both observed over two years. Because negative symptoms are
strongly linked t o functional outcome than positive symptoms, we predict that negative symptom
tasks will be the strongest predictor of functional decline in both domains.This project will provide
a next-generation CHR battery, tied to illness mechanisms and powered by cutting-edge computational
methods that can be used to facilitate the earliest possible detection of psychosis risk.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CAPER: Computerized Assessment of Psychosis Risk Supplement
-
批准号:10540475
-
项目类别:
-
资助金额:$2.36万
-
财政年份:2020
-
负责人:LAUREN M ELLMAN
-
依托单位:
CAPER: Computerized Assessment of Psychosis Risk
-
批准号:10361304
-
项目类别:
-
资助金额:$31.7万
-
财政年份:2020
-
负责人:LAUREN M ELLMAN
-
依托单位:
CAPER: Computerized Assessment of Psychosis Risk
-
批准号:10794659
-
项目类别:
-
资助金额:$2.54万
-
财政年份:2020
-
负责人:LAUREN M ELLMAN
-
依托单位:
CAPER: Computerized Assessment of Psychosis Risk
-
批准号:9980111
-
项目类别:
-
资助金额:$31.7万
-
财政年份:2020
-
负责人:LAUREN M ELLMAN
-
依托单位:
Maternal Inflammation During Pregnancy: Clinical and Neurocognitive Outcomes in Adult Offspring
-
批准号:10600865
-
项目类别:
-
资助金额:$60.74万
-
财政年份:2019
-
负责人:LAUREN M ELLMAN
-
依托单位:
Maternal Inflammation During Pregnancy: Clinical and Neurocognitive Outcomes in Adult Offspring
-
批准号:10380812
-
项目类别:
-
资助金额:$62.32万
-
财政年份:2019
-
负责人:LAUREN M ELLMAN
-
依托单位:
1/3-Community Psychosis Risk Screening: An Instrument Development Study Supplement
-
批准号:9675623
-
项目类别:
-
资助金额:$5.23万
-
财政年份:2017
-
负责人:LAUREN M ELLMAN
-
依托单位:
1/3 Community Psychosis Risk Screening: An Instrument Development Study
-
批准号:10203788
-
项目类别:
-
资助金额:$31.73万
-
财政年份:2017
-
负责人:LAUREN M ELLMAN
-
依托单位:
Fetal exposure to maternal stress and inflammation: Effects on neurodevelopment
-
批准号:8297405
-
项目类别:
-
资助金额:$40.78万
-
财政年份:2012
-
负责人:LAUREN M ELLMAN
-
依托单位:
Fetal exposure to maternal stress and inflammation: Effects on neurodevelopment
-
批准号:8596852
-
项目类别:
-
资助金额:$45.33万
-
财政年份:2012
-
负责人:LAUREN M ELLMAN
-
依托单位:
Fetal exposure to maternal stress and inflammation: Effects on neurodevelopment
-
批准号:8443812
-
项目类别:
-
资助金额:$44.22万
-
财政年份:2012
-
负责人:LAUREN M ELLMAN
-
依托单位:
海外基金